JP6363082B2 - 層状複水酸化物 - Google Patents

層状複水酸化物 Download PDF

Info

Publication number
JP6363082B2
JP6363082B2 JP2015535105A JP2015535105A JP6363082B2 JP 6363082 B2 JP6363082 B2 JP 6363082B2 JP 2015535105 A JP2015535105 A JP 2015535105A JP 2015535105 A JP2015535105 A JP 2015535105A JP 6363082 B2 JP6363082 B2 JP 6363082B2
Authority
JP
Japan
Prior art keywords
active
ldh
layered double
double hydroxide
intercalated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015535105A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016500667A (ja
JP2016500667A5 (enExample
Inventor
トンプソン，クレア
コーデロ，マルセロ レオナルド ブラボ
コーデロ，マルセロ レオナルド ブラボ
オヘア，ダーモット，マイケル
Original Assignee
オックスフォード ファーマサイエンス リミテッド
オックスフォード ファーマサイエンス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オックスフォード ファーマサイエンス リミテッド, オックスフォード ファーマサイエンス リミテッド filed Critical オックスフォード ファーマサイエンス リミテッド
Publication of JP2016500667A publication Critical patent/JP2016500667A/ja
Publication of JP2016500667A5 publication Critical patent/JP2016500667A5/ja
Application granted granted Critical
Publication of JP6363082B2 publication Critical patent/JP6363082B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2015535105A 2012-10-05 2013-10-01 層状複水酸化物 Expired - Fee Related JP6363082B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1217911.5 2012-10-05
GBGB1217911.5A GB201217911D0 (en) 2012-10-05 2012-10-05 Layered double hydroxides
PCT/GB2013/052554 WO2014053822A1 (en) 2012-10-05 2013-10-01 Layered double hydroxides

Publications (3)

Publication Number Publication Date
JP2016500667A JP2016500667A (ja) 2016-01-14
JP2016500667A5 JP2016500667A5 (enExample) 2016-11-17
JP6363082B2 true JP6363082B2 (ja) 2018-07-25

Family

ID=47294361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015535105A Expired - Fee Related JP6363082B2 (ja) 2012-10-05 2013-10-01 層状複水酸化物

Country Status (16)

Country Link
US (1) US9642919B2 (enExample)
EP (2) EP2929876B1 (enExample)
JP (1) JP6363082B2 (enExample)
KR (1) KR20150063559A (enExample)
CN (1) CN104853748A (enExample)
AU (2) AU2013326298B2 (enExample)
BR (1) BR112015007529A2 (enExample)
CA (1) CA2887059A1 (enExample)
EA (1) EA034124B1 (enExample)
GB (1) GB201217911D0 (enExample)
IL (1) IL237947B (enExample)
IN (1) IN2015DN02576A (enExample)
MX (1) MX2015004188A (enExample)
PH (1) PH12015500744A1 (enExample)
WO (1) WO2014053822A1 (enExample)
ZA (2) ZA201502510B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201520762D0 (en) * 2015-11-24 2016-01-06 Isis Innovation Novel pharmaceutical compositions
JP6557597B2 (ja) * 2015-12-25 2019-08-07 共栄社化学株式会社 層状複水酸化物
WO2018050799A1 (en) * 2016-09-15 2018-03-22 Paris Sciences Et Lettres - Quartier Latin A method for exchanging interlayer anions of a layered double hydroxide
CN109432450B (zh) * 2018-11-23 2021-07-13 北京化工大学 一种超分子纳米化学动力药物及其在肿瘤治疗方面的应用
CN113767066B (zh) * 2019-04-19 2024-01-05 国立研究开发法人物质·材料研究机构 氮系气体缓释剂和由其构成的氮系气体缓释体以及使用该缓释体的氮系气体的缓释方法、呼吸器具、包装体和缓释装置
MX2023004402A (es) * 2020-10-17 2023-10-12 David Anderson Formulacion y estabilizacion no covalente de derivados del acido olivetolico.

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS606619A (ja) * 1983-06-27 1985-01-14 Kyowa Chem Ind Co Ltd 鉄分欠乏症処置剤及びその製法
US5079203A (en) 1990-05-25 1992-01-07 Board Of Trustees Operating Michigan State University Polyoxometalate intercalated layered double hydroxides
JP3681480B2 (ja) * 1996-09-27 2005-08-10 エーザイ株式会社 薬物の不快な味を隠蔽する組成物
GB0030460D0 (en) * 2000-12-14 2001-01-24 Isis Innovation Drug delivery system
EP1345709B1 (en) 2000-12-19 2004-09-22 Babcock & Wilcox Volund APS A method for reducing the leaching of oxyanion forming elements, in particular chromium, from hazardous waste
JP2004091421A (ja) * 2002-09-03 2004-03-25 Tayca Corp アスコルビン酸を取り込んだ層状複水酸化物およびそれを含む化粧料組成物
US20040138511A1 (en) 2003-01-10 2004-07-15 James Butler Aromatic alkylation process with direct recycle
AU2003902178A0 (en) 2003-05-07 2003-05-22 Commonwealth Scientific And Industrial Research Organisation Stabilization of waste material
CN1297276C (zh) 2004-06-14 2007-01-31 北京化工大学 5－氨基水杨酸插层药物缓释剂及其制备方法
US20090108233A1 (en) * 2004-12-24 2009-04-30 The Univeristy Of Queensland Preparation of suspensions
US20060140994A1 (en) 2004-12-27 2006-06-29 Bagwell Alison S Application of an antimicrobial agent on an elastomeric article
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
CN100462071C (zh) * 2006-09-22 2009-02-18 北京化工大学 一种磁性超分子插层结构缓释型布洛芬及其制备方法
CN101493404B (zh) 2008-01-21 2011-08-10 安徽帝元生物科技有限公司 一种化肥养分控失剂控失率的检测方法
CN101440281B (zh) * 2008-11-25 2011-11-23 北京化工大学 苯并咔唑插层水滑石复合发光材料及其制备方法
ZA201000350B (en) 2009-02-05 2010-12-29 Univ Pretoria A degradable polymeric material
CN101507819B (zh) * 2009-03-27 2011-01-05 北京化工大学 一种大粒径药物插层水滑石及其制备方法
CN101597474B (zh) 2009-07-03 2012-10-17 北京化工大学 增甘磷插层结构选择性红外吸收材料及其制备方法与应用
US20110040006A1 (en) 2009-08-17 2011-02-17 Basf Se Compositions with Improved Dirt Pickup Resistance Comprising Layered Double Hydroxide Particles
CN102218043B (zh) 2011-06-14 2013-03-27 宁夏医科大学 Ldh超分子组装型阿司匹林缓释片及其制备方法

Also Published As

Publication number Publication date
WO2014053822A4 (en) 2014-05-30
JP2016500667A (ja) 2016-01-14
IL237947B (en) 2018-04-30
AU2013326298A1 (en) 2015-04-23
PH12015500744B1 (en) 2015-05-25
AU2013326298B2 (en) 2017-10-05
WO2014053822A1 (en) 2014-04-10
EA201590673A1 (ru) 2015-08-31
CN104853748A (zh) 2015-08-19
EP2903598A1 (en) 2015-08-12
EP2929876A1 (en) 2015-10-14
AU2017219016A1 (en) 2017-09-07
GB201217911D0 (en) 2012-11-21
IN2015DN02576A (enExample) 2015-09-11
US20150258212A1 (en) 2015-09-17
MX2015004188A (es) 2015-07-17
EA034124B1 (ru) 2019-12-30
EP2903598B1 (en) 2019-05-01
US9642919B2 (en) 2017-05-09
AU2017219016B2 (en) 2018-07-26
BR112015007529A2 (pt) 2017-07-04
KR20150063559A (ko) 2015-06-09
PH12015500744A1 (en) 2015-05-25
CA2887059A1 (en) 2014-04-10
ZA201702869B (en) 2018-08-29
ZA201502510B (en) 2017-09-27
EP2929876B1 (en) 2019-12-25

Similar Documents

Publication Publication Date Title
JP6363082B2 (ja) 層状複水酸化物
JP5457681B2 (ja) 水不溶性の無機リン酸塩結合剤を含む顆粒状物質
EP2462062B1 (en) Magnesium-iron layered double hydroxides, their manufacture and their use for treatment of hyperphosphataemia
Oh et al. LDH nanocontainers as bio-reservoirs and drug delivery carriers
Perioli et al. Intercalation and release of antiinflammatory drug diclofenac into nanosized ZnAl hydrotalcite-like compound
San Román et al. Drug release from layered double hydroxides and from their polylactic acid (PLA) nanocomposites
KR101951857B1 (ko) 마그헤마이트 또는 마그헤마이트/마그네타이트에 기초한 나노미립자 인산염 흡착제, 이의 제법 및 용도
EP3210600B1 (en) Mixed metal compounds used as antacids
EP2209479A1 (en) Mixed metal compounds for treatment of hyperphos phataemia
US10272057B2 (en) Layered double hydroxides
JP2016500667A5 (enExample)
JP2009545590A (ja) 酸化ストレスによる疾病の予防及び治療のための抗酸化剤
Shahabadi et al. Biological application of Layered double hydroxides in drug delivery systems
CA3116635A1 (en) Methods of treatment with mixed metal compounds
Chakraborty et al. Layered double hydroxides based ceramic nanocapsules as reservoir and carrier of functional anions
Fisher Pharmaceutical applications of layered double hydroxides
Sichani et al. A Novel Approach to Magnetic Core-Shell Nanostructures of MgAl Layered Double Hydroxide for Controlled Drug Release of Mefenamic Acid
Mondal Mg-Al Layered Double Hydroxide Nano-Carrier for Controlled Release of anti-inflammatory Drug
HK1121065B (en) Granular material comprising water-insoluble inorganic phosphate binders
HK1142525B (en) Mixed metal compounds for treatment of hyperphosphataemia
AU2013263790A1 (en) Granular Material Comprising Water-Insoluble Inorganic Phosphate Binders

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150407

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160927

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160927

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170623

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170704

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170926

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180410

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180605

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180627

R150 Certificate of patent or registration of utility model

Ref document number: 6363082

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees